These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. LH-RH agonists and antagonists. Schally AV; Coy DH; Arimura A Int J Gynaecol Obstet; 1980; 18(5):318-24. PubMed ID: 6110575 [TBL] [Abstract][Full Text] [Related]
5. LH-RH analogues: I. Their impact on reproductive medicine. Schally AV Gynecol Endocrinol; 1999 Dec; 13(6):401-9. PubMed ID: 10685334 [TBL] [Abstract][Full Text] [Related]
6. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female. Schally AV Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624 [TBL] [Abstract][Full Text] [Related]
7. Diverse effects of a potent LH-RH antagonist on the LH and FSH release. Kovács M; Koppán M; Mezó I; Teplán I Acta Biol Hung; 1994; 45(2-4):285-96. PubMed ID: 7725823 [TBL] [Abstract][Full Text] [Related]
9. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice. Redding TW; Schally AV; Radulovic S; Milovanovic S; Szepeshazi K; Isaacs JT Cancer Res; 1992 May; 52(9):2538-44. PubMed ID: 1568223 [TBL] [Abstract][Full Text] [Related]
10. Highly potent analogues of luteinizing hormone-releasing hormone containing D-phenylalanine nitrogen mustard in position 6. Bajusz S; Janaky T; Csernus VJ; Bokser L; Fekete M; Srkalovic G; Redding TW; Schally AV Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6318-22. PubMed ID: 2548207 [TBL] [Abstract][Full Text] [Related]
11. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms. Schally AV; Redding TW; Comaru-Schally AM Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868 [TBL] [Abstract][Full Text] [Related]
12. [History of clinical studies on hypothalamic hormone analogs in Mexico]. Schally AV; González Bárcena D Gac Med Mex; 2006; 142(4):315-25. PubMed ID: 17022307 [TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis. Schally AV Peptides; 1999; 20(10):1247-62. PubMed ID: 10573298 [TBL] [Abstract][Full Text] [Related]
14. Action of inhibitory LH-RH analogs in rat pituitary and luteal cell cultures. Spona J; Müntz R; Nicolics K; Seprödi J; Teplan I Endocrinol Exp; 1984 Jun; 18(2):101-7. PubMed ID: 6378589 [TBL] [Abstract][Full Text] [Related]
15. Changes in subcellular distribution of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) after treatment with the LH-RH antagonist cetrorelix. Halmos G; Schally AV Proc Natl Acad Sci U S A; 2002 Jan; 99(2):961-5. PubMed ID: 11805337 [TBL] [Abstract][Full Text] [Related]
16. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models. Roth C; Hegemann F; Hildebrandt J; Balzer I; Witt A; Wuttke W; Jarry H Pediatr Res; 2004 Jan; 55(1):126-33. PubMed ID: 14605254 [TBL] [Abstract][Full Text] [Related]
18. [Analogs of gonadoliberin. Value in physiology and therapeutics]. Charbonnel B Presse Med; 1994 Apr 30-May 7; 23(17):805-11. PubMed ID: 8078839 [TBL] [Abstract][Full Text] [Related]
19. Clinical applications of LHRH and its analogues. Sandow J Clin Endocrinol (Oxf); 1983 Jun; 18(6):571-92. PubMed ID: 6136347 [TBL] [Abstract][Full Text] [Related]
20. Luteinizing hormone-releasing hormone antagonist Cetrorelix regulates the expression of Galphas and Galphai protein subunits and adenylate cyclase activity in rat ovary, breast and pituitary. Collado B; Carmena MJ; Cortés J; Schally AV; Prieto JC Int J Oncol; 2004 Mar; 24(3):725-30. PubMed ID: 14767559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]